Q1 2026 quietly became one of the more active quarters for Australian SaaS M&A in recent memory. By our count there were 23 disclosed deals - up from 17 in Q4 2025 and 14 a year earlier. None of them were headline-grabbing trophy acquisitions. Most were the unglamorous work of consolidation and roll-up that actually shapes industries.

A few patterns deserve attention.

The mid-market is where the action is

The deal value distribution tells the story. Of the 23 disclosed deals, only three crossed AUD$50m. The median deal size was around AUD$8-12m. This is the roll-up phase - established platforms acquiring specialist tools, smaller competitors, or capability gaps in their stack.

Some of this is healthy market mechanics. Founders who started companies in 2015-2018 are coming up on a decade of grinding away at niche verticals, and a $5-15m exit looks attractive when growth has plateaued and capital is harder to come by than it was in 2021. We talked to two such founders this quarter - both said the deal felt like the right ending, not a defeat.

Some of it is buyer-side opportunism. Strategic acquirers know that valuations for sub-scale SaaS are roughly half what they were 30 months ago, and they’re moving while it lasts.

Vertical SaaS dominated

Of the 23 deals, 14 were vertical-specific - construction, legal, healthcare, agtech, property management, and a long tail of niche industries. Horizontal SaaS deals were thinner on the ground.

This tracks with what we’ve been hearing from VCs all year. Vertical SaaS with sticky workflows and embedded data has held up much better than horizontal point solutions. The acquirers know it. We saw two construction-tech roll-ups in Q1 alone, with one platform acquiring three sub-$5m ARR companies in a single quarter to fill out its product breadth.

The Australian Investment Council data on private capital flows aligns - vertical SaaS has consistently attracted disproportionate interest from PE-backed acquirers throughout 2025.

Foreign buyers stepped back, slightly

Local acquirers dominated the list more than they did in 2024. Roughly 70% of Q1 deals had Australian or NZ buyers, against around 55% in the equivalent quarter of 2024. The strong Australian dollar relative to USD through most of 2025-2026 has made cross-border acquisition into Australia less attractive on the margin, and US strategic buyers in particular have been more focused on tucking in domestic acquisitions than scouting Asia-Pacific.

The exception is UK and European buyers, who have been more active. Two of the five largest deals had European acquirers, and we expect this trend to continue through Q2-Q3 as European mid-market PE looks for growth markets to deploy capital.

The AI premium is selective

There’s been a lot of talk about AI-enabled SaaS commanding premium valuations. The Q1 data is more nuanced. AI-native companies (ones built around model capability) did command notably higher revenue multiples - 6-10x ARR was common where we could verify. But “AI-enabled” companies (traditional SaaS that bolted on some Copilot features) didn’t see meaningfully different multiples from peers without AI features.

The market has gotten quite good at distinguishing real AI capability from marketing veneer. This is healthy and probably overdue. We’ve heard from acquirer CTOs who now do specific technical due diligence on AI claims, including pulling out the actual prompts, models and integration patterns being used. Founders who can’t substantiate their AI story take a real haircut. Some are turning to specialist AI consultants ahead of due diligence to get the technical story properly substantiated before bankers come knocking.

What’s coming next

Talking to bankers and corporate development teams across Sydney and Melbourne, the pipeline for Q2 and Q3 looks heavy. A few things we’re watching:

More healthtech deals. Several established Australian healthtechs are at the scale where they need to either go public, raise serious growth capital, or sell. Public markets remain unfriendly to growth-stage tech, capital is selective, so M&A is the most likely path.

Fintech consolidation finally arriving. Australian fintech has been overdue for consolidation for two years. We expect Q2-Q3 to bring at least three meaningful deals as the larger players acquire their way into product areas they couldn’t build organically fast enough.

Less PE-led roll-ups. PE money has been more cautious in 2025-2026 than it was in 2021-2022. The deals we’re seeing are more strategic-led than financial-led. This means slightly slower pace but more sensible valuations.

The smaller story: founder fatigue

A pattern that doesn’t show up in the deal data but kept coming up in our conversations: founder fatigue. Many of the founders selling now were people who bootstrapped through COVID, raised in the 2021 frenzy at high valuations, and have spent three years working hard to grow into those valuations. By 2026, plenty are exhausted.

For some, an acquisition at a respectable but not spectacular outcome is genuinely the best ending available. We expect this to drive deal flow as much as any market dynamic over the next 18 months.

The takeaways

If you’re an Australian SaaS founder watching this market, three reads. First, multiples are recovering but slowly - don’t expect 2021 numbers any time soon. Second, vertical specialisation matters more than ever for exit valuations. Third, real AI capability commands real premium, but bolt-on AI features don’t move the needle.

If you’re an investor, the rollup phase is genuinely creating opportunity at the mid-market. Boring, but profitable. The 23 deals of Q1 2026 won’t make headlines but they’re quietly reshaping the Australian SaaS landscape.

We’ll be back with the Q2 data in early August. Expect the volume to keep climbing.